Skip to main content

Exchange Traded Concepts, LLC

SEC CIK
0001457320
Latest filing
Aug 11, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Exchange Traded Concepts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
75,528
Value
$6.85M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Exchange Traded Concepts, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202675,528$6.85M<0.1%+18,196+31.7%AddedHolders
Q1 202657,332$5.89M<0.1%−63,388−52.5%ReducedHolders
Q4 2025120,720$15.1M0.1%−5,222−4.1%ReducedHolders
Q3 2025125,942$16.9M0.2%−81,274−39.2%ReducedHolders
Q2 2025207,216$28.2M0.4%+102,734+98.3%AddedHolders
Q1 2025104,482$13.9M0.2%+90,432+643.6%AddedHolders
Q4 202414,050$1.59M<0.1%−2,925−17.2%ReducedHolders
Q3 202416,975$1.94M<0.1%+1,985+13.2%AddedHolders
Q2 202414,990$1.56M<0.1%+1,308+9.6%AddedHolders
Q1 202413,682$1.56M<0.1%+4,438+48.0%AddedHolders
Q4 20239,244$1.02M<0.1%−21,915−70.3%ReducedHolders
Q3 202331,159$3.02M0.1%+18,546+147.0%AddedHolders
Q2 202312,613$1.38M<0.1%−515−3.9%ReducedHolders
Q1 202313,128$1.33M<0.1%−76−0.6%ReducedHolders
Q4 202213,204$1.45M<0.1%−262−1.9%ReducedHolders
Q3 202213,466$1.30M<0.1%−7,055−34.4%ReducedHolders
Q2 202220,521$2.23M0.1%−1,541−7.0%ReducedHolders
Q1 202222,062$2.61M0.1%−39,740−64.3%ReducedHolders
Q4 202161,802$8.70M0.2%−3,521−5.4%ReducedHolders
Q3 202165,323$7.72M0.2%+45,708+233.0%AddedHolders
Q2 202119,615$2.27M0.1%+2,728+16.2%AddedHolders
Q1 202116,887$2.02M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.